NCT05847530已完成不适用
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Grading of Skin Aging and Photodamage
研究概览
简要总结
The primary objective of this pilot study is exploratory investigation evaluating the Potenza microneedle fractional radiofrequency (RF) device and may be used in combination with the Icon intense pulsed light (IPL) device.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Healthy male or female 18 years of age or older.
- •Presence of unwanted dermatologic condition suitable for treatment such as facial and/or neck wrinkles, skin laxity of face, neck or body, scars, acne scars or striae, or Vascular and/or pigment dyschromia
- •Ability to read, understand, and sign the Informed Consent Form
- •Understands and accepts the obligation not to undergo any other procedures in the areas to be treated and/or weight loss through the follow-up period.
- •Willing and able to comply with all study participation requirements including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study
排除标准
- •Is pregnant or of childbearing potential and not using (or willing to use) medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study.
- •Presence of an active systemic or local skin disease or condition that may affect wound healing or interfere with participation.
- •History of keloids or poor wound healing
- •Taking medication which is known to increase sensitivity to sunlight
- •Has a seizure disorders triggered by light
- •Cancer, malignant disease, skin pathology, condition or allergic reactions that could interfere with evaluation or with the use of typical ancillary medical treatments or care used before, during or after treatments
- •History of collagen, vascular or immunosuppressive or deficiency disorders
- •History of coagulative disorder or use of anticoagulant drugs within 2 weeks of study treatment
- •Use of steroids within 2 weeks of study treatments
- •Use of Accutane (isotretinoin) in the past 12 months
- •Previous surgical or cosmetic procedure to the target area in the last 6 to 12 months that could interfere with the treatment procedure and affect treatment outcome
- •Has an implanted pacemaker or defibrillator, metal pins or prosthetic joints
- •Allergic reaction to gold metal
- •Receiving or have received gold therapy
- •Photo-sensitive skin
- •Psycho-neurotic condition including alcohol or drug abuse
- •Unwilling or unable to adhere to all study requirements for treatment and follow-up
- •Has any condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation.
结局指标
主要结局
Grading of Skin Aging and Photodamage
时间窗: 90 days post last treatment
At the 90 day follow up, subjects will be graded on a scale of 0-4 (0 being none and 4 being severe) for the presence of skin aging and photodamage. The # of subjects with improvement will be reported.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast AbnormalitiesBreast CancerNCT00606931Naviscan PET Systems22
已完成
不适用
Non-invasive Measurement of Glucose with Advanced Spectroscopy Techniques and Machine Learning ModelsHealthyNCT06406075Liom Health AG43
已完成
不适用
Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling DeviceWrinklesFine LinesCrepey SkinAcne ScarsActive AcneEnlarged PoresLoose SkinNCT05254210Cynosure, Inc.10
进行中（未招募）
不适用
Physiotherapy Treatment for Gynecological Cancer Survivors with Urinary IncontinenceGynecologic CancerUrinary IncontinenceNCT03957434Université de Sherbrooke44
已完成
不适用
Pilot Study: AI Algorithm for Dermatology Referral OptimizationSkin DiseasesSkin ConditionNCT06228014AI Labs Group S.L200